SCHEMBL28896211

SCHEMBL28896211

CC(C)OCCn1c(=S)[nH]c(=O)c2[nH]cc(C3CC3)c21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 13/20 0.58
▸ OPRM1 P35372 1/20 0.58
▸ TSHR P16473 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTR1F P30939 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TPO P07202 9/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28896358 0.82 MPO (0.61) MPOOPRM1TSHRALDH1A1CYP1A2
Verdiperstat SCHEMBL1536607 0.74 MPO (1.00) MPOOPRM1TPOCYP3A4KCNH2
SCHEMBL1776521 0.71 MPO (0.61) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL18557964 0.69 MPO (0.66) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL28896602 0.68 MPO (0.65) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL28959839 0.65 MPO (0.60) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL28896535 0.65 MPO (0.40) MPOOPRM1ALDH1A1GAAMEN1
SCHEMBL23217965 0.64 MPO (0.58) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL28896613 0.64 MPO (0.61) MPOOPRM1TSHRALDH1A1CYP1A2
SCHEMBL28896616 0.63 MPO (0.57) MPOOPRM1TSHRALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403584-A 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-11-29 — — CN disclosed
Send feedback